» Articles » PMID: 9250271

Comorbidity Measurement in Elderly Female Breast Cancer Patients with Administrative and Medical Records Data

Overview
Publisher Elsevier
Specialty Public Health
Date 1997 Jun 1
PMID 9250271
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

The inter-rater reliability, cross-source (Medicare claims versus medical record) agreement, and ability to predict all-cause mortality of three aggregate comorbidity indices were evaluated in a group of 404 elderly, incident breast cancer cases identified from the Virginia Cancer Registry and linked to Medicare administrative data files. Comorbidity was based on both medical records and Medicare claims data using indices from Charlson et al (1987), Satariano and Ragland (1994), and Kaplan and Feinstein (1974). Inter-rater agreement was good for all indices (kappas > or = 0.80). Agreement between comorbidity indices measured by claims and medical records was considerably poorer (kappas between 0.30 and 0.40). However, claims-based and medical records-based comorbidity indices were similarly associated with mortality. For the Charlson index, the index best predicting survival, the adjusted relative risk for an increase from a lower to higher comorbidity category was 1.48 (95% confidence interval 1.23, 1.78) based on medical records compared to 1.53 (95% confidence interval 1.23, 1.93) based on Medicare claims. The claims-based Charlson index score still appeared to be associated with survival (relative risk = 1.30; 95% confidence interval = 1.00, 1.70) after controlling for the medical records-based score. This suggests that both comorbidity data sources add valuable prognostic information and, conversely, that the use of either source alone will result in some misclassification of comorbidity.

Citing Articles

Assessing Trends in Hospitalizations for Breast Cancer among Women in Korea: A Utilization of the Korea National Hospital Discharge In-depth Injury Survey (2006-2020).

Hwang J, Jang J J Epidemiol Glob Health. 2024; 14(2):411-419.

PMID: 38683484 PMC: 11176129. DOI: 10.1007/s44197-024-00229-1.


The Impact of Frailty Screening on Radiation Treatment Modification.

Fernandez-Camacho E, Ferrer-Ramos C, Morilllo-Macias V, Rodriguez-Cordon M, Sanchez-Iglesias A, Beato-Tortajada I Cancers (Basel). 2022; 14(4).

PMID: 35205820 PMC: 8870720. DOI: 10.3390/cancers14041072.


Comparison of Indexes to Measure Comorbidity Burden and Predict All-Cause Mortality in Rheumatoid Arthritis.

Huang Y, Chen J, Luo S, Kuo C J Clin Med. 2021; 10(22).

PMID: 34830741 PMC: 8618526. DOI: 10.3390/jcm10225460.


Prediction of Other-Cause Mortality in Older Patients with Breast Cancer Using Comorbidity.

de Boer A, Bastiaannet E, Putter H, Marang-van de Mheen P, Siesling S, de Munck L Cancers (Basel). 2021; 13(7).

PMID: 33915755 PMC: 8036543. DOI: 10.3390/cancers13071627.


Validation of an International Classification of Disease, 10th revision coding adaptation for the Charlson Comorbidity Index in United States healthcare claims data.

Beyrer J, Manjelievskaia J, Bonafede M, Lenhart G, Nolot S, Haldane D Pharmacoepidemiol Drug Saf. 2021; 30(5):582-593.

PMID: 33580525 PMC: 8252530. DOI: 10.1002/pds.5204.